Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DRUG FOR INHIBITING TUMOR CELL METASTASIS AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/016509
Kind Code:
A1
Abstract:
The text relates to a drug for inhibiting tumor cell metastasis and a use thereof. The present invention provides a use of a reagent for inhibiting the interaction between LGMN and an integrin or a β subunit thereof in the preparation of a drug for inhibiting tumor or tumor cell metastasis. The reagent or composition of the present invention can effectively inhibit tumor or tumor cell metastasis.

Inventors:
CHEN JIANFENG (CN)
LIU CUI (CN)
WANG JUNLEI (CN)
Application Number:
PCT/CN2022/111658
Publication Date:
February 16, 2023
Filing Date:
August 11, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE CHINESE ACAD OF SCIENCES (CN)
International Classes:
C07K14/435; A61K39/395; A61P35/00; C07K16/30; C12N5/10; C12N15/13; C12N15/63; G01N33/574
Foreign References:
CN101374856A2009-02-25
CN109694856A2019-04-30
CN105294831A2016-02-03
Other References:
ZHAO KEYU, XIULAN SU: "The role and therapeutic application of integrin in metastasis", CHINESE JOURNAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY, vol. 29, 9 December 2020 (2020-12-09), pages 381 - 385, XP093034688, ISSN: 1004-1850, DOI: 10.16705/j.cnki.1004-1850.2020.04.015
Attorney, Agent or Firm:
SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC (CN)
Download PDF: